EVOK EVOKE PHARMA INC Investments/Divestments 8-K Filing 2024 - Entry into a Material Definitive Agreement Evoke Pharma Inc entered into an underwriting agreement for the issuance and sale of common stock units and pre-funded warrant units, with expected net proceeds of approximately $6.1 million.Get access to all SEC 8-K filings of the EVOKE PHARMA INC